Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Moderna Stock Reverses Losses After 2-Year Bottom
10:35am, Thursday, 03'rd Aug 2023
Moderna Inc (NASDAQ:MRNA) stock is currently enjoying a modest post-earnings pop, reversing its losses after earlier dropping to a two-year low of $108.26.
Moderna's stock jumps 5% premarket after narrower-than-expected loss and revenue beat
08:02am, Thursday, 03'rd Aug 2023
Moderna Inc.'s stock MRNA, -3.26% rallied 5.5% in premarket trade Thursday, after the COVID vaccine market posted a narrower-than-expected second-quarter loss and revenue that was far below last year'
Moderna stock seen higher on better-than-feared earnings
07:24am, Thursday, 03'rd Aug 2023
Moderna Therapeutics Inc (NASDAQ:MRNA) stock points higher in premarket as it reported better than feared second quarter earnings The mNRA vaccine maker reported a net loss of US$1.4 billion on US$30
Moderna shares rise on better Covid vaccine outlook despite sharp drop in sales
07:09am, Thursday, 03'rd Aug 2023
Moderna and its rivals Pfizer and Novavax have all seen a steep drop in sales of Covid vaccines and treatments as the world moves on from the pandemic.
Moderna's stock jumps 5% premarket after narrower-than-expected loss and revenue beat
07:07am, Thursday, 03'rd Aug 2023
Moderna Inc.'s stock MRNA, -3.26% rallied 5.5% in premarket trade Thursday, after the COVID vaccine market posted a narrower-than-expected second-quarter loss and revenue that was far below last year'
Moderna sees up to $8 bln in 2023 COVID vaccine sales on private market hopes
06:32am, Thursday, 03'rd Aug 2023
Moderna Inc on Thursday raised its annual forecast for COVID-19 vaccine sales to up to $8 billion on hopes of a boost in the fall season as sales move to a private market in the United States from gov
3 ‘Strong Buy' Biotech Stocks You Should Be Loading Up On Now
03:17pm, Wednesday, 02'nd Aug 2023
Medical stocks, in general, aren't enjoying the market-wide reversal we're seeing in the back half of 2023. The Morningstar US Healthcare Index, which measures a range of biotech, pharma, medical devi
Should You Buy Moderna (MRNA) Ahead of Earnings?
11:57am, Wednesday, 02'nd Aug 2023
Moderna (MRNA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
3 Cheap Healthcare Stocks That Smart Investors Will Snap Up Now
11:45am, Tuesday, 01'st Aug 2023
Healthcare has been a laggard this year. A slowpoke, a dawdler, an idler.
Moderna (MRNA) to Report Q2 Earnings: Will It Beat Estimates?
02:08pm, Monday, 31'st Jul 2023
Investors' focus will likely be on updates on Moderna's (MRNA) pipeline, especially its late-stage pipeline candidates when it reports second-quarter earnings.
New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here's why
09:00am, Saturday, 29'th Jul 2023
Pfizer, Moderna and Novavax are slated to deliver new single-strain Covid shots targeting the omicron subvariant XBB.1.5 in September.
Cathie Wood Is Buying Up Shares of This Beaten-Down Biotech. Should You?
02:00pm, Thursday, 27'th Jul 2023
Superstar investor Cathie Wood bought shares of Moderna over a period of two days this week. The biotech company may become a respiratory vaccine giant -- with coronavirus, RSV, and flu vaccines -- in
Merck and Moderna launch late-stage trial of V940 with Keytruda as treatment for high-risk melanoma
06:55am, Wednesday, 26'th Jul 2023
Merck & Co. MRK, -1.16% and Moderna Inc. MRNA, -0.93% said Wednesday they have launched a Phase 3 trial of Moderna's V940 in combination with Merck's Keytruda as a treatment for patients with high-ris
The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023
05:55pm, Monday, 24'th Jul 2023
Growth investors are frequently looking for biotech stocks to buy. So what exactly is a biotech stock?
GSK Gears Up for Q2 Earnings: Will It Surpass Estimates?
02:28pm, Friday, 21'st Jul 2023
We expect GSK's specialty products like Cabenuva, Dovato, Bexsero, Breo Ellipta and Shingrix to drive second-quarter sales performance.
